SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
lonelymusic
Lv5
1540 积分
2024-10-26 加入
最近求助
最近应助
互助留言
In vivo generation of CAR macrophages via the enucleated mesenchymal stem cell delivery system for glioblastoma therapy
5天前
已完结
Sleep as a contributor to socioeconomic disparities in hypertension: The Midlife in the United States (MIDUS II) Study
1个月前
已关闭
SOCS1 protects acute myeloid leukemia against allogeneic T cell-mediated cytotoxicity
2个月前
已完结
The Paradox of Acute Myeloid Leukemia Responsiveness to Adoptive T-cell Therapy
2个月前
已完结
Cellular Kinetics and Biodistribution of Adoptive T Cell Therapies: from Biological Principles to Effects on Patient Outcomes
4个月前
已完结
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma
5个月前
已完结
CAR-T entering a new “phase”: Improving CAR-T function by harnessing phase separation
5个月前
已完结
Virus-free CRISPR knock-in of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells
5个月前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
6个月前
已完结
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
8个月前
已完结
没有进行任何应助
感谢,点赞,速度真快,帮大忙了
5天前
感谢,速度真快
2个月前
感谢,速度真快
2个月前
感谢,点赞
4个月前
感谢,点赞,速度真快
5个月前
感谢,点赞
5个月前
感谢,点赞,速度真快
5个月前
感谢,点赞,速度真快,帮大忙了,么么哒
6个月前
感谢,点赞,帮大忙了
8个月前
感谢,点赞,速度真快,帮大忙了,么么哒
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论